--- title: "600329.SH (600329.SH) — Related News" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/600329.SH/news.md" symbol: "600329.SH" name: "600329.SH" parent: "https://longbridge.com/en/quote/600329.SH.md" datetime: "2026-05-21T07:28:28.407Z" locales: - [en](https://longbridge.com/en/quote/600329.SH/news.md) - [zh-CN](https://longbridge.com/zh-CN/quote/600329.SH/news.md) - [zh-HK](https://longbridge.com/zh-HK/quote/600329.SH/news.md) --- # 600329.SH (600329.SH) — Related News ### [DRTG: Shanghai Shangshi and Shangshi Investment plan to publicly solicit a transferee for 100% equity of Shanghai Liuli Guang](https://longbridge.com/en/news/286898419.md) *2026-05-19T10:53:25.000Z* > DRTG announced that Shanghai Shangsuo Co., Ltd. and Shanghai Shangsuo Investment Development Co., Ltd. plan to publicly ### [The annual report has been disclosed, and high-dividend companies have emerged, with the highest reaching 11.8% (attached list)](https://longbridge.com/en/news/285324097.md) *2026-05-06T06:39:09.000Z* > As of April 30, the annual reports of A-shares have been fully disclosed, with over 5,000 listed companies publishing th ### [Penghua CSI Chinese Medicine ETF rose nearly 1%, driven by high dividends and innovation in the industry](https://longbridge.com/en/news/284294833.md) *2026-04-28T01:54:09.000Z* > Penghua CSI Chinese Medicine ETF rose nearly 1%, benefiting from high dividends and performance growth in the traditiona ### [DRTG: With industry height, cultural depth, and social warmth, it creates a new benchmark for high-quality development of century-old brands](https://longbridge.com/en/news/281870218.md) *2026-04-07T11:03:16.000Z* > On the evening of March 30th, DRTG, a century-old brand in traditional Chinese medicine and a leader in the modern Chine ### [DRTG's revenue has declined for three consecutive years, with last year's sales of the fast-acting rescue heart pill exceeding 2.1 billion yuan, and R&D investment of less than 200 million yuan](https://longbridge.com/en/news/281709747.md) *2026-04-05T11:42:15.000Z* > DRTG released its 2025 annual report, with total revenue of 4.917 billion yuan, a year-on-year decline of 32.7%; net pro ### [Ultra-high dividend yield stocks exposed, 47 stocks with the latest dividend yield exceeding 5%](https://longbridge.com/en/news/281587576.md) *2026-04-03T00:23:27.000Z* > As of April 2, 940 companies have announced their dividend plans for the 2025 annual report, with a proposed dividend am ### [A distribution of 23.4 yuan for every 10 shares! DRTG's revenue in 2025 is expected to decline by 30% year-on-year. What supports the generous dividend of 1.8 billion yuan?](https://longbridge.com/en/news/281171356.md) *2026-03-31T10:33:12.000Z* > DRTG (SH600329) plans to distribute a cash dividend of 23.4 yuan for every 10 shares. Despite a 32.70% year-on-year decl ### [Overview of A-share dividends and bonus shares: 2 stocks have their equity registration today](https://longbridge.com/en/news/281089877.md) *2026-03-30T23:51:56.000Z* > According to Wind data, today there are 2 A-shares undergoing equity registration, namely Sunlord and TWSC, with dividen ### [DRTG: Net profit of 2.131 billion yuan in 2025, a year-on-year decrease of 4.41%](https://longbridge.com/en/news/281004829.md) *2026-03-30T11:01:11.000Z* > Sina Finance reported on March 30 that DRTG announced that the operating income for 2025 is expected to be 4.917 billion